Cargando…
Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis
BACKGROUND/AIMS: Bisphosphonates are increasingly recognized for their anti-neoplastic properties, which are the result of their action on the mevalonate pathway. Our primary aim was to investigate the association between bisphosphonate use and survival in patients with pancreatic cancer. Since stat...
Autores principales: | Zylberberg, Haley M., Rustgi, Sheila D., Yang, Anthony, Aronson, Anne, Kessel, Elizabeth, Amin, Sunil, Lucas, Aimee L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444100/ https://www.ncbi.nlm.nih.gov/pubmed/34158422 http://dx.doi.org/10.5009/gnl20297 |
Ejemplares similares
-
Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis
por: Yang, Anthony, et al.
Publicado: (2021) -
Use of endoscopic ultrasound for pancreatic cancer from 2000 to 2016
por: Rustgi, Sheila D., et al.
Publicado: (2022) -
Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy
por: Fulop, Daniel J., et al.
Publicado: (2023) -
Adherence of bisphosphonate and decreased risk of clinical vertebral fracture in osteoporotic patients: A propensity score matching analysis
por: Kim, Seihee, et al.
Publicado: (2022) -
Propensity‐score matching with competing risks in survival analysis
por: Austin, Peter C., et al.
Publicado: (2018)